AJR Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nicolau, C.
Right arrow Articles by Brú, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nicolau, C.
Right arrow Articles by Brú, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
DOI:10.2214/AJR.04.1009
AJR 2006; 186:158-167
© American Roentgen Ray Society


Original Research

Importance of Evaluating All Vascular Phases on Contrast-Enhanced Sonography in the Differentiation of Benign from Malignant Focal Liver Lesions

Carlos Nicolau1, Ramon Vilana1, Violeta Catalá1, Luis Bianchi1, Rosa Gilabert1, Angeles García1 and Concepcio Brú1

1 All authors: Diagnosis Imaging Center, Hospital Clinic, Villarroel 170, Barcelona 08036, Spain.

OBJECTIVE. Our objective was to evaluate the accuracy of a blood-pool sonographic contrast agent in the late phase compared with the three vascular phases for differentiation between benign and malignant focal liver lesions.

SUBJECTS AND METHODS. In 152 patients (105 with chronic liver disease), 152 solid focal liver lesions characterized either by fine-needle biopsy or by dynamic CT or MRI were studied. The final diagnoses were metastasis for 24, hepatocellular carcinoma for 75, focal nodular hyperplasia for 13, regenerating or dysplastic nodule for 14, hemangioma for 22, cholangiocarcinoma for two, and another focal liver lesion for two. Real-time sonography was performed after a bolus injection of 2.4 mL of SonoVue, using a low mechanical index (< 0.2). All lesions were evaluated in the arterial, portal, and late phases; classified as benign or malignant; and correlated with final diagnoses.

RESULTS. For discrimination between malignant and benign focal liver lesions, evaluation of all vascular phases improved the sensitivity from 78.4% to 98% and the accuracy from 80.9% to 92.7%, compared with evaluation of the late phase alone. The increase in accuracy was higher in patients with chronic liver disease (16.3%) than in those without (2.1%).

CONCLUSION. Evaluation of SonoVue enhancement in all three vascular phases is superior to evaluation of SonoVue enhancement in the late phase alone, especially in patients with chronic liver disease.

Keywords: abdominal imaging • contrast media • dynamic sonography • liver disease • sonography


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
L. Chami, N. Lassau, D. Malka, M. Ducreux, S. Bidault, A. Roche, and D. Elias
Benefits of Contrast-Enhanced Sonography for the Detection of Liver Lesions: Comparison with Histologic Findings
Am. J. Roentgenol., March 1, 2008; 190(3): 683 - 690.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
T. K. Kim, H.-J. Jang, P. N. Burns, J. Murphy-Lavallee, and S. R. Wilson
Focal Nodular Hyperplasia and Hepatic Adenoma: Differentiation with Low-Mechanical-Index Contrast-Enhanced Sonography
Am. J. Roentgenol., January 1, 2008; 190(1): 58 - 66.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
B. Lanka, H.-J. Jang, T. K. Kim, P. N. Burns, and S. R. Wilson
Impact of Contrast-Enhanced Ultrasonography in a Tertiary Clinical Practice
J. Ultrasound Med., December 1, 2007; 26(12): 1703 - 1714.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
E. Quaia, M. D'Onofrio, P. Cabassa, F. Vecchiato, S. Caffarri, F. Pittiani, K. M. Wittkowski, and M. A. Cova
Diagnostic Value of Hepatocellular Nodule Vascularity After Microbubble Injection for Characterizing Malignancy in Patients with Cirrhosis
Am. J. Roentgenol., December 1, 2007; 189(6): 1474 - 1483.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
J. Murphy-Lavallee, H.-J. Jang, T. K. Kim, P. N. Burns, and S. R. Wilson
Are Metastases Really Hypovascular in the Arterial Phase?: The Perspective Based on Contrast-Enhanced Ultrasonography
J. Ultrasound Med., November 1, 2007; 26(11): 1545 - 1556.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
H.-J. Jang, T. K. Kim, P. N. Burns, and S. R. Wilson
Enhancement Patterns of Hepatocellular Carcinoma at Contrast-enhanced US: Comparison with Histologic Differentiation
Radiology, September 1, 2007; 244(3): 898 - 906.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
O. Catalano, V. Migaleddu, E. Quaia, and G. Caruso
Terminology for Contrast-Enhanced Sonography: A Practical Glossary
J. Ultrasound Med., June 1, 2007; 26(6): 717 - 730.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
S. R. Wilson, H.-J. Jang, T. K. Kim, and P. N. Burns
Diagnosis of Focal Liver Masses on Ultrasonography: Comparison of Unenhanced and Contrast-Enhanced Scans
J. Ultrasound Med., June 1, 2007; 26(6): 775 - 787.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
O. Catalano, F. Sandomenico, A. Nunziata, M. M. Raso, P. Vallone, and A. Siani
Transient Hepatic Echogenicity Difference on Contrast-Enhanced Ultrasonography: Sonographic Sign and Pitfall
J. Ultrasound Med., March 1, 2007; 26(3): 337 - 345.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Roentgen Ray Society.